This problem of valuing the shares needed by the tracker funds would be far less of a problem if the Phase III results were available beforehand.
The obvious move by institutional shareholders approached by the agents would have been to ask Insmed when the results are expected.
My gut feeling is that making the preliminary results available on time would simply be a question of assigning sufficient resources. Does anybody here see a barrier to that happening?
You of all people should know that the results will be released through a PR posted on the company website. There will be no cheating or online posting or any kind of "leaks".
I wasn't suggesting any kind of non-public access to the results. What does that leave?
Nope... Will Lewis will buy shares first.....
Sentiment: Strong Buy